These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7726506)

  • 41. Effects of areca nut extracts on the functions of human neutrophils in vitro.
    Hung SL; Chen YL; Wan HC; Liu TY; Chen YT; Ling LJ
    J Periodontal Res; 2000 Aug; 35(4):186-93. PubMed ID: 10983878
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the E test for antimicrobial susceptibility testing of Actinobacillus actinomycetemcomitans.
    Pajukanta R; Asikainen S; Saarela M; Alaluusua S; Jousimies-Somer H
    Oral Microbiol Immunol; 1992 Dec; 7(6):376-7. PubMed ID: 1299801
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protective effect of serum antibodies against a 110-kilodalton protein of Actinobacillus actinomycetemcomitans following periodontal therapy.
    Beikler T; Karch H; Ehmke B; Klaiber B; Flemmig TF
    Oral Microbiol Immunol; 1999 Oct; 14(5):281-7. PubMed ID: 10551154
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lack of lipoprotein-dependent effects on the cytotoxic interactions of Actinobacillus actinomycetemcomitans leukotoxin with human neutrophils.
    Johansson A; Claesson R; Belibasakis G; Makoveichuk E; Hänström L; Olivecrona G; Kalfas S
    APMIS; 2002 Dec; 110(12):857-62. PubMed ID: 12645663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro activity of cefpodoxime proxetil (U-76,252; CS-807) against Neisseria gonorrhoeae.
    Schaadt RD; Yagi BH; Zurenko GE
    Antimicrob Agents Chemother; 1990 Feb; 34(2):371-2. PubMed ID: 2109583
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interaction of human salivary mucin MG2, its recombinant N-terminal region and a synthetic peptide with Actinobacillus actinomycetemcomitans.
    Liu B; Rayment SA; Soares RV; Oppenheim FG; Offner GD; Fives-Taylor P; Troxler RF
    J Periodontal Res; 2002 Dec; 37(6):416-24. PubMed ID: 12472835
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microbiological evaluation of cefpodoxime proxetil.
    Wiedemann B; Luhmer E; Zühlsdorf MT
    Drugs; 1991; 42 Suppl 3():6-12. PubMed ID: 1726210
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparison of pharmacokinetics/pharmacodynamics of cefdinir, cefpodoxime proxetil and cefaclor against common bacteria of community acquired infections].
    Xiao YH; Gao L; Li Y; Lü Y; Liu J; Liu Y
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1867-71. PubMed ID: 15631795
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prediction of bacterial susceptibility to cefpodoxime by using the ceftriaxone minimum inhibitory concentration result.
    Jones RN; Zurenko GE
    Diagn Microbiol Infect Dis; 1993; 17(4):313-6. PubMed ID: 8112047
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunoproteomics of Actinobacillus actinomycetemcomitans outer-membrane proteins reveal a highly immunoreactive peptidoglycan-associated lipoprotein.
    Paul-Satyaseela M; Karched M; Bian Z; Ihalin R; Borén T; Arnqvist A; Chen C; Asikainen S
    J Med Microbiol; 2006 Jul; 55(Pt 7):931-942. PubMed ID: 16772422
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extracts of Prevotella intermedia and Actinobacillus actinomycetemcomitans inhibit alkaline phosphatase activity in osteoblastic cells in vitro.
    Murata T; Ansai T; Takehara T; Kobayashi S; Haneji T
    Oral Dis; 1997 Jun; 3(2):106-12. PubMed ID: 9467351
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of the capsular polysaccharide-like serotype-specific antigen in resistance of Actinobacillus actinomycetemcomitans to phagocytosis by human polymorphonuclear leukocytes.
    Yamaguchi N; Kawasaki M; Yamashita Y; Nakashima K; Koga T
    Infect Immun; 1995 Dec; 63(12):4589-94. PubMed ID: 7591110
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5556 recent clinical isolates from five medical centers.
    Sader HS; Jones RN; Washington JA; Murray PR; Gerlach EH; Allen SD; Erwin ME
    Diagn Microbiol Infect Dis; 1993; 17(2):143-50. PubMed ID: 8243035
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cell surface-associated enolase in Actinobacillus actinomycetemcomitans.
    Hara H; Ohta H; Inoue T; Ohashi T; Takashiba S; Murayama Y; Fukui K
    Microbiol Immunol; 2000; 44(5):349-56. PubMed ID: 10888352
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cefdinir-induced modification of the susceptibility of bacteria to the antibacterial activity of human serum and polymorphonuclear neutrophils.
    Pruul H; McDonald PJ
    Eur J Clin Microbiol Infect Dis; 1993 Mar; 12(3):170-6. PubMed ID: 8508815
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation of cefpodoxime susceptibility with cephalothin and cefuroxime for urinary tract isolates.
    Bookstaver DA; Bland CM; Woodberry MW; Mansell KB
    J Med Microbiol; 2014 Feb; 63(Pt 2):218-221. PubMed ID: 24214230
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetic-pharmacodynamic modelling of antibacterial activity of cefpodoxime and cefixime in in vitro kinetic models.
    Liu P; Rand KH; Obermann B; Derendorf H
    Int J Antimicrob Agents; 2005 Feb; 25(2):120-9. PubMed ID: 15664481
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of different (pseudo)halide substrates on peroxidase-mediated killing of Actinobacillus actinomycetemcomitans.
    Ihalin R; Loimaranta V; Lenander-Lumikari M; Tenovuo J
    J Periodontal Res; 1998 Oct; 33(7):421-7. PubMed ID: 9842507
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of an immunoglobulin Fc receptor of Actinobacillus actinomycetemcomitans.
    Mintz KP; Fives-Taylor PM
    Infect Immun; 1994 Oct; 62(10):4500-5. PubMed ID: 7927715
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neutrophil modulation by Actinobacillus actinomycetemcomitans. II. Phagocytosis and development of respiratory burst.
    Ashkenazi M; White RR; Dennison DK
    J Periodontal Res; 1992 Sep; 27(5):457-65. PubMed ID: 1328589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.